Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Get tomorrow's read on MEDS — free
One email every weekday morning: what changed across MEDS and ~1,400 other microcaps, every claim linked to the filing.
$52Kcash + short-term investments as of Mar 31, 2026
0.1 moestimated runway (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts])
$-15.1Mstockholders' equity as of Mar 31, 2026
$27.1Mpublic float (10-K cover)
125.7Mshares outstanding as of May 19, 2026 · was 104.9M Mar 6, 2026
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 175 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date
Signal
Evidence
Score
Sep 16, 2026
▼Convertible note
“convertible note” language in 8-K (EX-4.1) filed 2026-09-16 filing
~0.1 months runway: liquidity $51,730 as of 2026-03-31, burn $10,855,029/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing
39
Mar 31, 2026
▼Negative equity
Stockholders' equity $-15,062,449 as of 2026-03-31 filing
31
Mar 31, 2026
▼Cash < current liabilities
Liquidity $51,730 vs current liabilities $32,198,867 filing
22
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans